`Trademark Trial and Appeal Board
`P.O. Box 1451
`Alexandria, VA 22313-1451
`
` Mailed: November 22, 2011
`
`Opposition No. 91184464
`Opposition No. 91184465
`
`Medimmune, Inc.
`
`
`v.
`
`
`SYGNIS Pharma AG
`
`
`
`
`
`am
`
`
`
`
`
`
`
`
`
`
`
`
`Ann Linnehan, Attorney
`
`Opposer’s consented motion (filed October 25, 2011) to
`
`
`
`further suspend this consolidated proceeding for ninety days
`
`and to reset remaining trial dates, including the close of
`
`discovery, is granted.
`
`
`
`Because the parties are negotiating for possible
`
`settlement of this case, proceedings herein are suspended
`
`until through January 26, 2012, subject to the right of either
`
`party to request resumption at any time. See Trademark Rule
`
`2.117(c).
`
`
`
`Inasmuch as opposer has provided the Board with an
`
`updated report of the parties settlement discussions as
`
`previously required, the parties are reminded that there is a
`
`continuing obligation to provide good cause in the form of
`
`detailed progress reports for any further extension or
`
`suspension request.
`
`
`
`Opposition Nos. 91184464 and 91184465
`
`
`
`In the event that there is no word from either party
`
`concerning the progress of their negotiations, upon
`
`conclusion of the suspension period, proceedings shall
`
`resume on January 27, 2012 without further notice or order
`
`from the Board, upon the schedule set out in opposer’s
`
`motion and copied below.
`
`
`
`In each instance, a copy of the transcript of testimony
`
`together with copies of documentary exhibits, must be served
`
`on the adverse party within thirty days after completion of
`
`the taking of testimony. Trademark Rule 2.l25.
`
`Briefs shall be filed in accordance with Trademark Rule
`
`2.128(a) and (b). An oral hearing will be set only upon
`
`request filed as provided by Trademark Rule 2.l29.
`
`If, during the suspension period, either of the parties
`
`or their attorneys should have a change of address, the
`
`Board should be so informed.
`
`2